Loading...
OTCM
HDVY
Market cap41kUSD
Jul 09, Last price  
0.00USD
1Q
0.00%
Jan 2017
-99.23%
IPO
-99.99%
Name

Health Discovery Corp

Chart & Performance

D1W1MN
OTCM:HDVY chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-0.56%
Revenues
0k
5015226,998203,88957,90565,73161,803396,176118,9541,585,5171,053,6071,032,12744,60143,51244,95144,3001,518,8061,00000
Net income
0k
-229,595-2,205,088-3,159,016-2,595,759-2,698,927-2,147,461-2,016,871-7,042,552-2,524,948-440,737-774,920176,641-587,061-2,068,619-873,887-795,4741,561,000-759,00000
CFO
0k
-457,427-1,503,551-2,421,070-1,135,134-1,467,118-1,309,832-1,298,940-5,396,098-2,381,777-1,968,217-1,767,198-736,169-608,605-465,957-314,005-275,5362,202,713-1,379,00000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Health Discovery Corporation (HDC) is a U.S.-based enterprise specializing in pattern recognition. The company utilizes sophisticated mathematical approaches to scrutinize data, primarily within the realm of molecular diagnostics, with the goal of identifying underlying patterns. Its portfolio of intellectual property encompasses Support Vector Machines (SVMs), a class of mathematical algorithms, alongside biomarkers – which are biological indicators or genetic markers signifying specific disease conditions – and its proprietary Fractal Genomic Modeling technology. HDC was founded in 2001 and maintains its principal operations in Atlanta, Georgia.
IPO date
Nov 09, 2001
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT